Delivery Order SPE2DB22D1202-SPE2DB24FUPD1

Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 24,000 units of CREON DR 100S capsules. The contract, valued at $1,914.46, has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of CREON DR 4563849287 capsules in 100-count packages. The potential value of this contract is $1,366.89 with a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger indefinite...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of 36,000 units of CREON DR 100s capsules, valued at $1,441.08. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of the pharmaceutical product CREON DR 100S capsules. The contract has a potential value of $19,565.08 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is not operating under any set-aside designation for this award. In addition to this delivery...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Cencora, Inc., has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,423.81, is for the provision of 24,000 unit capsules of the medication CREON DR 100S. This contract does not have a set-aside designation. The award is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide 36,000 units of CREON DR 100S capsule medication. The $6,266.30 contract has a completion date of February 22, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 2025 to deliver pharmaceutical...
Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 36,000 unit capsules of the pharmaceutical product CREON DR 100s. The potential value of this delivery order is $2,343.24, with a completion date of March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 36,000 units of the pharmaceutical product CREON DR 100S capsules. The potential value of this order is $1,171.68, with a completion date of February 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of the pharmaceutical product CREON DR 100S capsules. The order has a potential value of $4,459.11 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under a set-aside designation. This delivery order is part of a larger...
The U.S. Defense Logistics Agency (DLA) awarded a $1,282.77 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 36,000 units of CREON DR 36,000 unit capsules. This delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUPD1
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Cencora, Inc., was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 24,000 units of CREON DR 100S capsules. The $1,357.76 contract has a completion date of February 1, 2024 and does not contain a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, providing pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC enables Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities worldwide in support of the Department of Defense.

Generated 5/1/24, 10:19 AM